in cooperation with Hungarian Society of Gastroenterology, Croatian Society of Gastroenterology, Romanian Society of Gastroenterology, Slovenian Society of Gastroenterology, Serbian Association for Gastroenterologists
Course Directors: László Herszényi, Peter Malfertheiner
| 8:30 | Welcome and Introduction to the course by László Herszényi |
| GERD/BARRETT’S ESOPHAGUS Chairs: P. Malfertheiner, J. Mayerle, T. Wittmann | |
| 8:30 | Management of Barrett’s Esophagus Summary of international guidelines András Rosztóczy (Hungary) |
| 8:45 | Q & A / Discussion |
| 8:50 | Endoscopic Diagnosis: new development in imaging Summary of international guidelines Jochen Weigt (Germany) |
| 9:05 | Q & A / Discussion |
| 9:10 | Case scenario: Management of Barrett’s: to ablate or not to ablate (difficult to fit within recommendation) István Rácz (Hungary) |
| 9:25 | Audience Questions & Voting |
| Local guidelines and practice differ from International | |
| 09:35 | Why & How in Hungary - László Herszényi |
| 09:40 | Why & How in Serbia - Tomica Milosavljevic |
| 09:45 | Why & How in Slovenia - Nejc Sever |
| 09:50 | Why & How in Romania - Dan Dumitrascu |
| 09:55 | Why & How in Croatia - Marco Banic |
| 10:00 | Q & A / Discussion |
| EOSINOPHILIC ESOPHAGITIS Chairs: Z. Tulassay, S. Bataga, M. Banic | |
| 10:05 | Management of Esophagitis Summary of international guidelines Julia Mayerle (Germany) |
| 10:20 | Q & A / Discussion |
| 10:25 | Preventive and therapeutic approaches in esophageal cancer – the surgeon’s perspective Péter Kupcsulik (Hungary) |
| 10:40 | Q & A / Discussion |
| 10:45 | Case scenario: Patient with confirmed Esophagitis (difficult to fit within recommendation): not responsive to elimination diet, PPI therapy and swallowed topic steroids Tomica Milosavljevic (Serbia) |
| 11:00 | Audience Questions & Voting |
| 11:05 | Coffee Break |
| HELICOBACTER PYLORI Chairs: T. Matysiak, D. Stimac, I. Rácz | |
| 11:25 | Management of H. pylori infection Summary of international guidelines Peter Malfertheiner (Germany) |
| 11:40 | Q & A / Discussion |
| 11:45 | H. pylori resistance in Europe Francis Megraud (France) |
| 12:00 | Q & A / Discussion |
| 12:05 | Indications for therapy, diagnostics Márk Juhász (Hungary) |
| 12:20 | Q & A / Discussion |
| 12:25 | Case scenario: Patient non responsive to second-line-therapy (difficult to fit within recommendation) György Buzás (Hungary) |
| 12:40 | Audience Questions & Voting Local guidelines and practice differ from International |
| Local guidelines and practice differ from International | |
| 12:45 | Why & How in Hungary - László Herszényi |
| 12:50 | Why & How in Serbia - Tomica Milosavljevic |
| 12:55 | Why & How in Slovenia - Gregor Novak |
| 13:00 | Why & How in Romania - Dan Dumitrascu |
| 13:00 | Why & How in Croatia - Marco Banic |
| 13:05 | Q & A / Discussion |
| 13:10 | Lunch Break |
| DYSPEPSIA Chairs: H. Herszényi, D. Dumitrascu, T. Milosavljevic | |
| 14:15 | Approach of dyspepsia: algorithm for diagnosis and treatment Dan Dumitrascu (Romania) |
| 14:30 | Q & A / Discussion |
| 14:35 | Case scenario: Patient with functional or organic dyspepsia Simona Bataga (Romania) |
| 14:50 | Audience Questions & Voting |
| GASTRIC PRECANCEROUS LESIONS - GASTRIC CANCER I. Chairs: J. Weigt, F. Megraud, I. Altorjay | |
| 14:55 | Management of gastric precancerous lesions Summary of international guidelines Tamara Matysiak-Budnik (France) |
| 15:10 | Q & A / Discussion |
| 15:15 | Gastric precancerous lesion: pathologist’s point of view Barna Bogner (Hungary) |
| 15:30 | Q & A / Discussion |
| 15:35 | Endoscopic detection and management of early neoplastic lesions – the role of new endoscopic techniques Jochen Weigt (Germany) |
| 15:50 | Q & A / Discussion |
| 15:55 | The impact of primary and secondary prevention Davor Stimac (Croatia) |
| 16:10 | Q & A / Discussion |
| 16:15 | Case scenario: Treatment of early gastric cancer: endoscopic or surgical treatment? (difficult to fit within recommendation) Heinz Hammer (Austria) |
| 16:30 | Audience Questions & Voting |
| 16:35 | Coffee Break |
| GASTRIC PRECANCEROUS LESIONS - GASTRIC CANCER II, Chairs: H. Hammer, M. Banic, Á. Vincze | |
| 16:55 | Gastric cancer: when and which adjuvant therapy? Summary of international guidelines Tamás Pintér (Hungary) |
| 17:10 | Q & A / Discussion |
| 17:15 | Operable gastric cancer: current follow-up strategies, late-effects and psycho-social implications of treatments Matej Horvat (Slovenia) |
| 17:30 | Q & A / Discussion |
| Local guidelines and practice differ from International | |
| 17:35 | Why and How in Hungary - László Herszényi |
| 17:40 | Why and How in Serbia - Tomica Milosavljevic |
| 17:45 | Why and How in Slovenia - Matej Horvat |
| 17:50 | Why and How in Romania - Dan Dumitrascu |
| 17:55 | Why & How in Croatia - Marco Banic |
| 18:00 | Q & A / Discussion |
| 18:05 | Closing, concluding remarks by Peter Malfertheiner |